Isis Pharmaceuticals to lease new 176,000 square foot research facility from BioMed Realty Trust

Published on April 5, 2010 at 12:15 PM · 1 Comment

BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has expanded its strategic real estate partnership with Isis Pharmaceuticals, Inc.  BioMed extended its lease for Isis' current facility at Faraday Avenue in Carlsbad, California and added a lease for a new build-to-suit project, increasing the total leased space to approximately 204,700 square feet.

Under the terms of the new agreement, Isis will lease 100% of a new 176,000 square foot, state-of-the-art research facility to be constructed by BioMed at the Carlsbad Oaks North Business Park in Carlsbad. Upon completion of construction, Isis will lease the new building for a 20-year term and consolidate the majority of its operations in the new facility.

Concurrently, Isis extended to December 31, 2031 the lease for its approximately 28,700 square foot, recently upgraded manufacturing facility, which it currently occupies at BioMed's nearby Faraday Avenue property.  

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Filipino | Bahasa | Русский | Svenska | Polski
  1. raymond pawley raymond pawley United States says:

    My Fiancee has colorectal cancer that was totally removed Jan. 2008: however idt did metastized to her lungs and has been there for the entire period. Tow of the small growths has just reached a size whereby 2 weeks ago they could byopsy it and verify that it was in fact colorectal cancer. They started a new target therapy and had her 1st week round.

    Would your therapy be something we may look into?

    Please advise.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment